Discontinuation report ACT NABILONE

Last updated on 2019-11-01 History
Report ID 97581
Drug Identification Number 02393603
Brand name ACT NABILONE
Common or Proper name NABILONE 1MG CAPSULES
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) NABILONE
Strength(s) 1MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50's &100's
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-10-31
Actual discontinuation date 2019-10-31
Remaining supply date 2019-10-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments ACT Product is discontinued and is transitioning to the TEVA DIN
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-11-01 English Compare
v2 2019-10-31 French Compare
v1 2019-10-31 English Compare